Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

NCT02597127

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +19 more
Locations
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Midwest Institute For Clinical Research Indianapolis, Indiana, United States
  • Mount Sinai Icahn School of Medicine New York, United States
  • Metabolic And Atherosclerosis Research Center Cincinnati, Ohio, United States
View all 54 locations
View Trial Details
Completed

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

NCT01907087

Conditions
Batten Disease, CLN2 Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • University Hamburg-Eppendorf Hamburg, Germany
  • Bambino Gesù Children's Hospital Rome, Italy
  • Guy's & St. Thomas NHS Foundation Trust London, United Kingdom
View Trial Details
Completed

IN-TANDEM Familial Hypercholesterolemia Pilot Study

NCT03253432

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations
  • Lancaster General Hospital Lancaster, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions